Speaker illustration

Mr David Carcedo

Barcelona ()

How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations?

Event: ESC Preventive Cardiology 2021

Topic: Health Economics

Session: Rapid fire abstracts - Secondary Prevention and Rehabilitation

Thumbnail

This platform is supported by

logo Novo Nordisk